We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+0.71%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$22.9B
AUM Growth
+$1.01B
Cap. Flow
-$5.41B
Cap. Flow %
-23.63%
Top 10 Hldgs %
20.65%
Holding
1,090
New
128
Increased
343
Reduced
93
Closed
104

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.8M
2
AAPL icon
Apple
AAPL
+$35.4M
3
AMZN icon
Amazon
AMZN
+$34.6M
4
AESC
The AES Corporation
AESC
+$30.3M
5
ADBE icon
Adobe
ADBE
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 15.1%
2 Financials 8.11%
3 Healthcare 7.32%
4 Consumer Discretionary 6.91%
5 Communication Services 6.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTPBU
726
DELISTED
Gores Technology Partners II, Inc. Units
GTPBU
$400K ﹤0.01%
40,000
FZT.U
727
DELISTED
FAST Acquisition Corp. II Units, each consisting of one share of Class A common stock and one-quarter of one redeemable warrant
FZT.U
$396K ﹤0.01%
40,000
GSEVU
728
DELISTED
Gores Holdings VII, Inc. Units
GSEVU
$395K ﹤0.01%
40,000
NWL icon
729
Newell Brands
NWL
$2.24B
$388K ﹤0.01%
17,525
FACA.U
730
DELISTED
Figure Acquisition Corp. I Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
FACA.U
$384K ﹤0.01%
40,000
SIERU
731
DELISTED
Sierra Lake Acquisition Corp. Unit
SIERU
$368K ﹤0.01%
+36,903
New +$367K
CMLS
732
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$363K ﹤0.01%
29,649
+3,416
+13% +$41.2K
HCIIU
733
DELISTED
Hudson Executive Investment Corp. II Unit
HCIIU
$348K ﹤0.01%
35,000
SLAMU
734
DELISTED
Slam Corp. Unit
SLAMU
$297K ﹤0.01%
30,000
SCLEU
735
DELISTED
Broadscale Acquisition Corp. Units
SCLEU
$297K ﹤0.01%
30,000
EPWR.U
736
DELISTED
Empowerment & Inclusion Capital I Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant
EPWR.U
$264K ﹤0.01%
26,400
CFFVU
737
DELISTED
CF Acquisition Corp. V Unit
CFFVU
$254K ﹤0.01%
25,000
SDACU
738
DELISTED
Sustainable Development Acquisition I Corp. Unit
SDACU
$252K ﹤0.01%
25,000
GSQD.U
739
DELISTED
G Squared Ascend I Inc. Units, each consisting of one Class A ordinary share and one-fifth of one Warrant to acquire one Class A ordinary share
GSQD.U
$252K ﹤0.01%
25,000
ACII.U
740
DELISTED
Atlas Crest Investment Corp. II Units, each consisting of one Class A common stock, $.0001 par value, and one-fourth of one redeemable warrant
ACII.U
$250K ﹤0.01%
25,000
IRAAU
741
DELISTED
Iris Acquisition Corp Units
IRAAU
$249K ﹤0.01%
25,000
TMUS icon
742
T-Mobile US
TMUS
$196B
$248K ﹤0.01%
+1,939
New +$270K
ANAC.U
743
DELISTED
Arctos NorthStar Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
ANAC.U
$248K ﹤0.01%
25,100
IWB icon
744
iShares Russell 1000 ETF
IWB
$47.9B
$227K ﹤0.01%
939
+2
+0.2% +$497
AGG icon
745
iShares Core US Aggregate Bond ETF
AGG
$138B
$224K ﹤0.01%
1,950
PFF icon
746
iShares Preferred and Income Securities ETF
PFF
$13.2B
$214K ﹤0.01%
5,525
LMACU
747
DELISTED
Liberty Media Acquisition Corporation Unit
LMACU
$207K ﹤0.01%
20,000
SCHF icon
748
Schwab International Equity ETF
SCHF
$65.5B
$201K ﹤0.01%
+10,372
New +$206K
ENNVU
749
DELISTED
ECP Environmental Growth Opportunities Corp. Unit
ENNVU
$201K ﹤0.01%
20,000
GTPAU
750
DELISTED
Gores Technology Partners, Inc. Units
GTPAU
$200K ﹤0.01%
20,000

Similar funds

Calamos Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Calamos Advisors held 1,090 positions worth $22.9B, up 4.6% from $21.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Calamos Advisors withdrew a net $5.41B in Q3 2021, closing 104 positions and reducing 93 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $31.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in AstraZeneca worth $17.8M.

  • Calamos Advisors's largest Q3 2021 buy was AstraZeneca: 148,454 shares worth $17.8M.
  • Calamos Advisors added most to Microsoft in Q3 2021, an estimated $41.8M increase.
  • Calamos Advisors's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $236M.
  • Calamos Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $31.2M.
  • Calamos Advisors's ten largest holdings make up 21% of its $22.9B portfolio in Q3 2021.
  • Calamos Advisors opened 128 new positions and closed 104 in Q3 2021.
  • Calamos Advisors's portfolio value rose 4.6% quarter-over-quarter to $22.9B.

Based on Calamos Advisors's 13F filing for Q3 2021, filed 26 Oct 2021.